Laurel Messer, PhD, RN
Assistant Professor, Pediatrics-Barbara Davis Center

Photo
Download CV
Graduate Schools :
  • MPH/MSPH, University of Colorado Health Sciences Center (2009)
  • PhD, University of Colorado College of Nursing (2019)
Undergraduate Schools:
  • BA, Colorado College (CO) (1999)
  • BSN, Quinnipiac University (CT) (2005)
Languages: English
Department: Pediatrics-Barbara Davis Center

Professional Titles

  • Assistant Professor of Pediatrics
  • Nurse Scientist

Publications

  • Tanenbaum ML, Messer LH, Wu CA, Basina M, Buckingham BA, Hessler D, Mulvaney SA, Maahs DM, Hood KK. Help when you need it: Perspectives of adults with T1D on the support and training they would have wanted when starting CGM. Diabetes Res Clin Pract. 2021 Sep 14;180:109048. [Epub ahead of print] PubMed PMID: 34534592
  • Shang T, Zhang JY, Bequette BW, Raymond JK, Coté G, Sherr JL, Castle J, Pickup J, Pavlovic Y, Espinoza J, Messer LH, Heise T, Mendez CE, Kim S, Ginsberg BH, Masharani U, Galindo RJ, Klonoff DC. Diabetes Technology Meeting 2020. J Diabetes Sci Technol. 2021 Jul;15(4):916-960. PubMed PMID: 34196228
  • Kudva YC, Laffel LM, Brown SA, Raghinaru D, Pinsker JE, Ekhlaspour L, Levy CJ, Messer LH, Kovatchev BP, Lum JW, Beck RW, Gonder-Frederick L. Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial. Diabetes Technol Ther. 2021 Oct;23(10):673-683. PubMed PMID: 34115959
  • Messer LH, Berget C, Pyle L, Vigers T, Cobry E, Driscoll KA, Forlenza GP. Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes. Diabetes Technol Ther. 2021 Jun 21. [Epub ahead of print] PubMed PMID: 34096789
  • Messer LH, Weinzimer SA. Practical Diabetes Technology: Overcoming Barriers in the Real World. Diabetes Technol Ther. 2021 Jun;23(S2):S159-S168. PubMed PMID: 34061638
  • Berget C, Akturk HK, Messer LH, Vigers T, Pyle L, Snell-Bergeon J, Driscoll KA, Forlenza GP. Real-world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed-loop use. Diabetes Obes Metab. 2021 Sep;23(9):2048-2057. PubMed PMID: 34010499
  • Schoelwer MJ, Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cobry EC, Messer LH, Cengiz E, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, Buckingham BA, Lal RA, Oliveri MC, Kollman CC, Dokken BB, Cherñavvsky DR, Beck RW, DeBoer MD. Predictors of Time-in-Range (70-180?mg/dL) Achieved Using a Closed-Loop Control System. Diabetes Technol Ther. 2021 Jul;23(7):475-481. PubMed PMID: 33689454
  • Messer LH, Berget C, Ernst A, Towers L, Slover RH, Forlenza GP. Initiating hybrid closed loop: A program evaluation of an educator-led Control-IQ follow-up at a large pediatric clinic. Pediatr Diabetes. 2021 Jun;22(4):586-593. PubMed PMID: 33502062
  • Cobry EC, Kanapka LG, Cengiz E, Carria L, Ekhlaspour L, Buckingham BA, Hood KK, Hsu LJ, Messer LH, Schoelwer MJ, Emory E, Ruedy KJ, Beck RW, Wadwa RP, Gonder-Frederick L. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Diabetes Technol Ther. 2021 Jun;23(6):401-409. PubMed PMID: 33404325
  • Forlenza GP, Buckingham BA, Brown SA, Bode BW, Levy CJ, Criego AB, Wadwa RP, Cobry EC, Slover RJ, Messer LH, Berget C, McCoy S, Ekhlaspour L, Kingman RS, Voelmle MK, Boyd J, O'Malley G, Grieme A, Kivilaid K, Kleve K, Dumais B, Vienneau T, Huyett LM, Lee JB, O'Connor J, Benjamin E, Ly TT. First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2021 Jun;23(6):410-424. PubMed PMID: 33325779
  • O'Malley G, Messer LH, Levy CJ, Pinsker JE, Forlenza GP, Isganaitis E, Kudva YC, Ekhlaspour L, Raghinaru D, Lum J, Brown SA. Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical Trial. Diabetes Technol Ther. 2021 Apr;23(4):245-252. PubMed PMID: 33155824
  • Messer LH, Campbell K, Pyle L, Forlenza GP. Basal-IQ technology in the real world: satisfaction and reduction of diabetes burden in individuals with type 1 diabetes. Diabet Med. 2021 Jun;38(6):e14381. PubMed PMID: 32767401
  • Escobar, E., Towers, L., Berget, C., Vigers, T., Pyle, L. Messer, L.H., Cobry, E., Slover, R.H., Wadwa, R.P., Driscoll, K.A., Forlenza, G.P. (2021) Psychosocial Impacts of the t:slim X2 Pump with Control-IQ Technology (CIQ) in a Clinical Population of Youth with Type 1 Diabetes (T1D) After 6 Months of Use. Poster presented at the International Society of Pediatric and Adolescent Diabetes 47th Annual Conference, virtual.
  • Forlenza G, Vigers T, Berget C, Messer L, Lal R, Basina M, Maahs D, Hood K, Buckingham B, Wilson D, Wadwa RP, Driscoll K, Pyle L. Predicting Success with a First-Generation Hybrid Closed Loop Artificial Pancreas System Among Children, Adolescents, and Young Adults with Type 1 Diabetes: a Model Development and Validation Study. Presented as an ePoster (Forlenza presenting author) at the International Society for Pediatric and Adolescent Diabetes Conference, Virtual 2021.
  • Zaharieva DP, Messer LH, Paldus B, O'Neal DN, Maahs DM, Riddell MC. Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents with Type 1 Diabetes. Can J Diabetes. 2020 Jun 8. [Epub ahead of print] PubMed PMID: 33011134
  • Berget C, Lange S, Messer L, Forlenza GP. A clinical review of the t:slim X2 insulin pump. Expert Opin Drug Deliv. 2020 Sep 9;:1-13. [Epub ahead of print] PubMed PMID: 32842794
  • Messer LH, Campbell K, Pyle L, Forlenza GP. Basal-IQ technology in the real world: satisfaction and reduction of diabetes burden in individuals with type 1 diabetes. Diabet Med. 2020 Aug 7;:e14381. [Epub ahead of print] PubMed PMID: 32767401
  • Cobry EC, Berget C, Messer LH, Forlenza GP. Review of the Omnipod(®) 5 Automated Glucose Control System Powered by Horizon™ for the treatment of Type 1 diabetes. Ther Deliv. 2020 Aug;11(8):507-519. PubMed PMID: 32723002
  • Laffel LM, Kanapka LG, Beck RW, Bergamo K, Clements MA, Criego A, DeSalvo DJ, Goland R, Hood K, Liljenquist D, Messer LH, Monzavi R, Mouse TJ, Prahalad P, Sherr J, Simmons JH, Wadwa RP, Weinstock RS, Willi SM, Miller KM. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020 Jun 16;323(23):2388-2396. PubMed PMID: 32543683
  • Messer LH, Tanenbaum ML, Cook PF, Wong JJ, Hanes SJ, Driscoll KA, Hood KK. Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets. Diabetes Technol Ther. 2020 Oct;22(10):760-767. PubMed PMID: 32163719
  • Messer LH, Weinzimer SA. Practical Implementation of Diabetes Technology: Real-World Use. Diabetes Technol Ther. 2020 Feb;22(S1):S119-S129. PubMed PMID: 32069150
  • Messer LH, Berget C, Vigers T, Pyle L, Geno C, Wadwa RP, Driscoll KA, Forlenza GP. Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatr Diabetes. 2020 Mar;21(2):319-327. PubMed PMID: 31885123
  • Berget C, Messer LH, Vigers T, Frohnert BI, Pyle L, Wadwa RP, Driscoll KA, Forlenza GP. Six months of hybrid closed loop in the real-world: An evaluation of children and young adults using the 670G system. Pediatr Diabetes. 2020 Mar;21(2):310-318. PubMed PMID: 31837064
  • Zaharieva DP, Messer LH, Paldus B, O'Neal DN, Maahs DM, Riddell MC. Glucose Control During Physical Activity and Exercise Using Closed Loop Technology in Adults and Adolescents with Type 1 Diabetes. Can J Diabetes. 2020 Dec;44(8):740-749. PubMed PMID: 33011134
  • Berget C, Lange S, Messer L, Forlenza GP. A clinical review of the t:slim X2 insulin pump. Expert Opin Drug Deliv. 2020 Dec;17(12):1675-1687. PubMed PMID: 32842794
  • Messer LH, Tanenbaum ML, Cook PF, Wong JJ, Hanes SJ, Driscoll KA, Hood KK. Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets. Diabetes Technol Ther. 2020 Oct;22(10):760-767. PubMed PMID: 32163719
  • Messer LH, Sousa K, Cook PF. Applying two minds theory to self-management of Type 1 diabetes. Res Nurs Health. 2019 Dec;42(6):500-508. PubMed PMID: 31587327
  • Saunders A, Messer LH, Forlenza GP. MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy. Expert Rev Med Devices. 2019 Oct;16(10):845-853. PubMed PMID: 31540557
  • Berget C, Messer LH, Forlenza GP. A Clinical Overview of Insulin Pump Therapy for the Management of Diabetes: Past, Present, and Future of Intensive Therapy. Diabetes Spectr. 2019 Aug;32(3):194-204. PubMed PMID: 31462873
  • Messer LH, Berget C, Forlenza GP. A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm. Diabetes Technol Ther. 2019 Aug;21(8):462-469. PubMed PMID: 31140878
  • Berget C, Nii P, Wyckoff L, Patrick K, Brooks-Russell A, Messer LH. Equipping School Health Personnel for Diabetes Care with a Competency Framework and Pilot Education Program. J Sch Health. 2019 Sep;89(9):683-691. PubMed PMID: 31245846
  • Ekhlaspour L, Forlenza GP, Chernavvsky D, Maahs DM, Wadwa RP, Deboer MD, Messer LH, Town M, Pinnata J, Kruse G, Kovatchev BP, Buckingham BA, Breton MD. Closed loop control in adolescents and children during winter sports: Use of the Tandem Control-IQ AP system. Pediatr Diabetes. 2019 Sep;20(6):759-768. PubMed PMID: 31099946
  • Forlenza GP, Ekhlaspour L, Breton M, Maahs DM, Wadwa RP, DeBoer M, Messer LH, Town M, Pinnata J, Kruse G, Buckingham BA, Cherñavvsky D. Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial. Diabetes Technol Ther. 2019 Apr;21(4):159-169. PubMed PMID: 30888835
  • Berget C, Thomas SE, Messer LH, Thivener K, Slover RH, Wadwa RP, Alonso GT. A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic. J Diabetes Sci Technol. 2019 Mar 12;:1932296819835183. [Epub ahead of print] PubMed PMID: 30862242
  • Messer LH, Cook PF, Tanenbaum ML, Hanes S, Driscoll KA, Hood KK. CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring. J Diabetes Sci Technol. 2019 Nov;13(6):1135-1141. PubMed PMID: 30854886
  • Forlenza GP, Kushner T, Messer LH, Wadwa RP, Sankaranarayanan S. Factory-Calibrated Continuous Glucose Monitoring: How and Why It Works, and the Dangers of Reuse Beyond Approved Duration of Wear. Diabetes Technol Ther. 2019 Apr;21(4):222-229. PubMed PMID: 30817171
  • Messer LH. Practical Implementation of Diabetes Technology: It Is Time. Diabetes Technol Ther. 2019 Feb;21(S1):S148-S159. PubMed PMID: 30785323
View All (37 Total) View Less

Professional Memberships

  • American Diabetes Association, Member
  • International Society for Pediatric and Adolescent Diabetes, Advisory Council Member

Practice Locations

Barbara Davis Center for Childhood Diabetes - Specialty Clinic
1775 Aurora Ct
Aurora, CO 80045
303-724-2323

Specialty Information

Specialties
  • Certified Diabetes Care and Education Specialist, Certificate (2007)
Conditions & Treatments
  • Endocrine System (Hormones)

General Information

Graduate Schools:
  • MPH/MSPH, University of Colorado Health Sciences Center (2009)
  • PhD, University of Colorado College of Nursing (2019)
Undergraduate Schools:
  • BA, Colorado College (CO) (1999)
  • BSN, Quinnipiac University (CT) (2005)
Download CV
Languages: English
Department: Pediatrics-Barbara Davis Center
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;